| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/09/2004 | US20040173778 homogeneous clonal populations derived therefrom with enhanced suppressive activity and their uses in the regulation of immune responses and for the identification and characterization of suppressor T cell specific molecules |
| 09/09/2004 | US20040173527 Process for removing viruses in fibrinogen solutions and fibrinogen obtained by said process |
| 09/08/2004 | EP1454984A1 Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 09/08/2004 | EP1454917A2 Diabody-type bispecific antibody |
| 09/08/2004 | EP1454641A2 Porous implantable medical device seeded with mammalian cells |
| 09/08/2004 | EP1454628A2 Medical use of p38/JTV-1 |
| 09/08/2004 | EP1454624A1 Antiviral, antibacterial pharmaceutical composition of cantharidic anhydride and method of preparation thereof |
| 09/08/2004 | EP1454140A2 Diagnosis and treatment of atherosclerosis |
| 09/08/2004 | EP1453955A2 Cell constructs cultured in vitro, preparation and uses |
| 09/08/2004 | EP1453954A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof |
| 09/08/2004 | EP1453953A1 Method for producing stem cells with increased developmental potential |
| 09/08/2004 | EP1453951A2 Method for carrying out the ex vivo expansion and ex vivo differentiation of multipotent stem cells |
| 09/08/2004 | EP1453949A2 Production of cell suspensions |
| 09/08/2004 | EP1453853A2 Mixture of peptides originating from a nef protein and applications thereof |
| 09/08/2004 | EP1453840A1 Phosphonates useful as modulators of t-gamma-9-delta-2 lymphocyte activity |
| 09/08/2004 | EP1453567A1 Catheter for cell delivery in tissue |
| 09/08/2004 | EP1453556A1 Method for forming matrices of hardened material |
| 09/08/2004 | EP1453548A2 Compositions for and methods of treating and preventing sirs/sepsis |
| 09/08/2004 | EP1453547A2 Adeno-associated virus (aav) serotype 8 sequences, vectors containing same, and uses therefor |
| 09/08/2004 | EP1453537A1 Composition for viral preservation |
| 09/08/2004 | EP1453536A1 Composition for the preservation of viruses |
| 09/08/2004 | EP1453533A1 Migration of hematopoietic stem cells and progenitor cells to th e liver |
| 09/08/2004 | EP1453527A2 Method for obtaining oestrogen from mare urine |
| 09/08/2004 | EP1453526A2 Pharmaceutical composition for topical treatment of skin disorders and skin wounds |
| 09/08/2004 | EP1453382A2 Methods and compositions for correction of cardiac conduction disturbances |
| 09/08/2004 | EP1180121B9 Long lasting insulinotropic peptides |
| 09/08/2004 | EP1141021B1 Removal/purification of serum albumins |
| 09/08/2004 | EP1073420A4 Specially devised neuronal implants for reconstruction of damaged central nervous system |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | CN1527722A Smallpox vaccine |
| 09/08/2004 | CN1527716A Anti-virus agent |
| 09/08/2004 | CN1527697A Immune modulation device for use in animals |
| 09/08/2004 | CN1526730A Erythrocytosis factor and its production process |
| 09/08/2004 | CN1526444A Composition for immunological activation |
| 09/08/2004 | CN1526429A Lithiasis treating Chinese medicine prepn |
| 09/08/2004 | CN1526413A Dry rhizopus bacteria suspension and its prepn process and use |
| 09/08/2004 | CN1526412A Making process of nanometer level pearl powder and shell powder |
| 09/08/2004 | CN1526411A Technological process of preparing water soluble marine pearl powder |
| 09/08/2004 | CN1165618C Polynucleotide immunogenic agents |
| 09/08/2004 | CN1165343C Indications for use as medicaments of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses |
| 09/08/2004 | CN1165335C Compound preparation for curing diarrhea |
| 09/08/2004 | CN1165331C Chinse medicine for treating tuberculosis |
| 09/08/2004 | CN1165324C Medicine 'Luolixiao' for treating scrofula |
| 09/08/2004 | CN1165323C Gastrosis treating Chinese medicine prepn. |
| 09/08/2004 | CN1165321C Recipe and prepn process of spleen and kidney invigorating medicine |
| 09/08/2004 | CN1165318C Health tea for reducing blood fat |
| 09/08/2004 | CN1165317C Preparation of alternate pseudomonads ecological microbial preparation |
| 09/08/2004 | CN1165316C Method for preparing nano level pearli powder |
| 09/08/2004 | CN1165299C Composition for treatment of psoriasis |
| 09/07/2004 | US6787517 Agent and methods for treating pain |
| 09/07/2004 | US6787357 Plasma-derived fibrin-based matrices and tissue |
| 09/07/2004 | US6787355 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 09/07/2004 | US6787353 Self-renewing restricted stem cells for treating neurological diseases; can differentiate into multiple neuronal but not glial phenotypes |
| 09/07/2004 | US6787351 Composition for the prevention of preferential viral infections |
| 09/07/2004 | US6787335 Polynucleotides and polypeptides which are diagnostic markers for mammary gland cancer. |
| 09/07/2004 | US6787333 Retrovirus isolated from humans |
| 09/07/2004 | US6787159 Process for the preparation of a cosmetic extract from marine ooze |
| 09/07/2004 | US6787146 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 09/07/2004 | CA2222642C Micro-encapsulated lactobacilli for medical applications |
| 09/07/2004 | CA2173594C Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| 09/02/2004 | WO2004074465A1 Human salivary gland-origin stem cell |
| 09/02/2004 | WO2004074457A2 Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
| 09/02/2004 | WO2004074435A2 Methods for identifying and administering agents that bias the immune response via dendritic cells |
| 09/02/2004 | WO2004074190A1 Magnetic fluid treatment device and uses thereof |
| 09/02/2004 | WO2004073728A2 Compositions comprising fetal hemoglobin and bacterial endotoxin and optionally additional fetal liver components |
| 09/02/2004 | WO2004073724A1 Endogenous pharmaceutical composition produced on the basis of an intentional activation of humoral mediators of the nerve endings of cerebral cortex |
| 09/02/2004 | WO2004073613A2 A medicine and food |
| 09/02/2004 | WO2004061091A3 Insulin producing cells |
| 09/02/2004 | WO2004032881A3 Implantation of encapsulated biological materials for treating diseases |
| 09/02/2004 | WO2004030624A3 Compositions and methods for inhibiting pathogenic growth |
| 09/02/2004 | WO2004002421A3 Method for the treatment of multiple sclerosis |
| 09/02/2004 | WO2003084344A3 Method of improving absorption of vitamin e by a pet animal |
| 09/02/2004 | US20040172665 Compositions and methods for treating enzyme deficiency |
| 09/02/2004 | US20040171807 involves engineering a recombinant shuttle vector comprising a nucleic acid cassette encoding prokaryotic green fluorescent protein (GFP) operably linked to regulatory sequences which permit its expression in a host cell |
| 09/02/2004 | US20040171804 for drug screening cancer, osteoporosis, obesity, Alzheimer's disease drugs; genetic engineering; kits |
| 09/02/2004 | US20040171579 anticoagulant piscine glucosaminoglycans; coating agent for invasive medical equipment |
| 09/02/2004 | US20040171569 that directs formation of a recombinant virus upon introduction into a cell |
| 09/02/2004 | US20040171557 treating or educating said cells ex vivo in the presence of: intermediary metabolite; antigens or epitopes associated with said disease, or the immune-mediated inflammatory response; re-administering to said subject said treated or educated cells |
| 09/02/2004 | US20040171528 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171527 Regulation of immune responses by manipulation of intermediary metabolite levels |
| 09/02/2004 | US20040171526 Raise intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171522 Raise the intracellular or extracellular or serum level of metabolite in subject |
| 09/02/2004 | US20040171153 Stem cell |
| 09/02/2004 | US20040171151 Method for preparing a cartilaginous neo-tissue |
| 09/02/2004 | US20040171147 Cytotherapeutics, cytotherapeutic units and methods for treatments using them |
| 09/02/2004 | US20040171146 Adipose-derived stem cells and lattices |
| 09/02/2004 | US20040171123 fusion protein of an antibody that binds to human epidermal growth factor receptor-2 (HER2) and albumin with long shelf-life; stabilizing therapeutic proteins such as antibodies by conjugating them to albumin |
| 09/02/2004 | US20040171115 Comprises hematopoietic protein modulator for use in proliferation and diffefrentiation of bone marrow cells |
| 09/02/2004 | US20040171111 Polypeptide of a p53 protein-specific murin a/t-cell receptor, nucleic acids coding therefor and use thereof |
| 09/02/2004 | US20040171090 Screening for cytotoxic t-lymphocyte recognition antigen associated with human t-cell leukemia virus infected cells for diagnosing and prognosing inflammation and cell proliferation disorders |
| 09/02/2004 | US20040171045 Assay for predicting cell activity |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170993 Methods for diagnosing and treating heart disease |
| 09/02/2004 | US20040170697 Amniotic apoptosis modulating substances |
| 09/02/2004 | US20040170696 Honey-based composition for relief of occasional heartburn and digestive disorders |
| 09/02/2004 | US20040170670 Cosmetic sponges |
| 09/02/2004 | US20040170649 uses optimal solvent systems such that the lipid envelope around the viral particle is dissolved while the viral particle remains intact; autologous vaccines |
| 09/02/2004 | US20040170640 Methods for preparing and delivering adjuvant compositions |
| 09/02/2004 | US20040170617 treating with an antibacterial agent and/or a probiotic mixture; used for Attention Deficit Disorder, Depression, biopolar disorder, Alzheimer's disease, Parkinson's Disease, Whipple's Disease, Tourette's Syndrome, Asperger's syndrome, Pervasive Development Disorder, gastrointestinal disorders, etc. |
| 09/02/2004 | US20040170615 Methods and compositions using compounds from fetal cells and tissues to improve condition of skin |